查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941478

生物感測器市場規模、佔有率和趨勢分析報告：按技術、應用、最終用途、地區和細分市場預測（2026-2033 年）

Biosensors Market Size, Share & Trends Analysis Report By Technology (Electrochemical, Thermal, Piezoelectric), By Application (Medical, Bioreactor, Agriculture), By End Use (PoC Testing, Food Industry), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

生物感測器市場概覽

2025年全球生物感測器市場規模估計為322.1億美元，預計2033年將達到639.6億美元。

預計從 2026 年到 2033 年，生物感測器市場將以 9.12% 的複合年成長率成長。生物感測器需求不斷成長的原因包括：醫療應用多樣化、糖尿病和高血壓等慢性病和非傳染性疾病的盛行率不斷上升、對小型診斷設備的需求量很大以及技術的快速進步。

對健康監測和健身追蹤日益成長的需求，以及對個人化數位健康日益濃厚的興趣，是推動市場成長的主要動力。此外，基於奈米技術的生物感測器預計將在包括食品分析、成像和微生物活性監測在內的各個工業領域中廣泛應用。對非侵入式和穿戴式生物感測器的日益青睞、醫療設備和特種藥品的日益普及，以及各製造商之間不斷加強的研發合作，都在推動全球市場的整合。

此外，生物感測器能夠對心率、睡眠模式、血氧飽和度、步數等生理指標進行連續、即時監測，為消費者和醫療保健專業人員提供可操作的數據。例如，根據亞利桑那大學健康科學學院2025年6月發表的一篇論文，先進的感測器平台將利用深度學習模型，根據高頻生物特徵資料預測生理事件，例如分娩的開始和壓力反應。這些設備將作為早期警報系統，在症狀出現之前檢測健康風險，從而將醫療保健管理從被動應對轉變為主動預防，並減輕延遲診斷和急診護理的負擔。

同樣，Cardiosense公司的CardioTag也是這趨勢的典型代表。它是一款獲得FDA批准的穿戴式式多模態心臟監測感測器，整合了心電圖（ECG）、光電容積脈搏波描記法（PPG）和地震心動圖（SCG）訊號。 CardioTag利用先進的人工智慧演算法分析這些高精度訊號，能夠早期檢測心臟衰竭，進行全面的心臟評估，並提供個人化的治療指導。它可在臨床和家庭環境中非侵入性測量心臟動態、血流動力學（射血時間等）和容量狀態。

此外，人工智慧、機器學習和感測器小型化技術的進步顯著提升了穿戴式裝置的功能和精確度。人工智慧演算法的整合實現了即時數據處理、預測分析和個人化回饋。在病患管理方面，Medtronic的Edge人工智慧胰島素輸注系統融合了生物感測器資料流，為動態調整胰島素劑量提供臨床層級的即時決策支援。該系統展示了人工智慧穿戴裝置無需外部連接即可實現響應迅速的個人化干涉的能力，從而支持門診精準醫療。此外，由於指尖感測器測量精度的提高以及24小時佩戴舒適度的提升，智慧戒指也越來越受歡迎。

此外，產業內日益增多的夥伴關係與夥伴關係也促進了市場成長。例如，法國公司與國際公司之間的合作有助於擴大生產規模並進入全球市場，例如利文斯頓公司於2025年6月與一家全球生物感測器和穿戴式裝置領域的Start-Ups合作。這種擴張反映了健身愛好者和都市區消費者對相關產品的日益成長的需求，從而推動了個人化健身、健康和生活方式應用的發展。

「自新冠疫情以來，診斷行業發生了變化，穿戴式技術變得越來越重要，人工智慧的影響力也越來越大。我們相信，與LinkSens的合作將使我們能夠顯著擴大市場佔有率，同時保持行業領先地位。”

「FlexMedical致力於執行長，」FlexMedical首席執行官兼聯合創始人凱文法倫表示。

“透過此次合作，我們將整合功能化技術，拓展我們的生物感測器產品線，從而提供從軟性PCB和印刷電極到全功能感測器平台的端到端解決方案。我們將共同簡化從研發到量產的流程，加速創新診斷解決方案的交付。”

Minh Le，LinkSens 醫療保健副總裁

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 生物感測器市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 生物感測器市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析

第4章 生物感測器市場：按應用分類的估算與趨勢分析

  • 全球生物感測器市場應用變化分析
  • 全球生物感測器市場規模及趨勢分析（按應用領域分類，2021-2033 年）
  • 醫療保健
    • 膽固醇
    • 血糖
    • 血氣分析儀
    • 妊娠測試
    • 藥物發現
    • 感染疾病
  • 食物毒性
  • 反應器
  • 農業
  • 環境
  • 其他

第5章 生物感測器市場：依技術、預測與趨勢分析

  • 全球生物感測器市場技術趨勢與波動分析
  • 全球生物感測器市場規模及趨勢分析（按技術分類，2021-2033 年）
  • 熱感的
  • 電化學
  • 壓電
  • 光學

第6章：生物感測器市場：最終用途、預測與趨勢分析

  • 全球生物感測器市場按最終用途分類的差異分析
  • 全球生物感測器市場規模及趨勢分析（按最終用途分類，2021-2033 年）
  • 居家醫療診斷
  • PoC測試
  • 食品工業
  • 研究所
  • 安全與生物防禦

第7章 生物感測器市場：區域、預測與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司/競爭對手分類
  • 策略規劃
  • 2025年商業市場分析
  • 公司簡介/列表
    • Abbott Laboratories
    • Medtronic
    • Biosensors International Group
    • Pinnacle Technology, Inc.
    • Dupont.
    • Sensirion AG
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche AG
    • Siemens Healthineers
    • Zimmer & Peacock AS
    • Metrohm AG
    • DexCom, Inc.
    • Universal Biosensors, Inc.
    • Johnson & Johnson Services, Inc.
    • Nix Biosensors
    • Cyrcadia Health
    • Lifescan
Product Code: 978-1-68038-321-8

Biosensors Market Summary

The global biosensors market size was estimated at USD 32.21 billion in 2025 and is projected to reach USD 63.96 billion by 2033, growing at a CAGR of 9.12% from 2026 to 2033. The demand for biosensors is increasing due to the diversity of medical applications, growing prevalence of chronic and non-communicable diseases such as diabetes and hypertension, high demand for compact diagnostic devices, and rapid technological advancements.

The increasing demand for health monitoring and fitness tracking, coupled with rising interest in personalized digital wellness, is a primary driver in the growth of the market. In addition, nanotechnology-based biosensors are expected to have wide application scope in various industries, such as food analysis, imaging, and microbial activity monitoring. The global market is consolidating due to the growing preference for non-invasive wearable biosensors, rising popularity of medical devices & specialty drugs, and increasing research collaborations between various manufacturers.

Moreover, biosensors enable continuous, real-time monitoring of physiological metrics such as heart rate, sleep patterns, blood oxygen saturation, and steps taken, providing actionable data for consumers and healthcare professionals. For instance, according to an article published by the University of Arizona Health Sciences in June 2025, advanced sensor platforms use deep learning models to predict physiological events, including labor onset and stress response, from high-frequency biometric data. These devices serve as an early warning system to detect health risks prior to symptom onset. This approach transforms health management from episodic to proactive intervention, reducing the burden of late diagnoses and emergency care.

Similarly, the Cardiosense CardioTag is a significant example of this trend. It is an FDA-cleared, multimodal wearable sensor for cardiac monitoring, combining ECG (electrocardiogram), PPG (photoplethysmogram), and SCG (seismocardiogram) signals. It leverages advanced AI algorithms to analyze these high-fidelity signals for early heart failure detection, comprehensive cardiac assessment, and personalized therapy guidance, enabling noninvasive measurement of cardiac mechanics, hemodynamics (such as left ventricular ejection time), and volume status in both clinical and home settings.

Furthermore, advances in artificial intelligence, machine learning, and sensor miniaturization have significantly enhanced the functionality and accuracy of wearable devices. Integration of AI algorithms enables real-time data processing, predictive analytics, and personalized feedback. In patient management, Medtronic's edge AI-enabled insulin delivery systems demonstrate clinical-grade, real-time decision-making by fusing biosensor streams for dynamic insulin dose adjustment. This system highlights the capability of AI-enabled wearables to deliver responsive, personalized interventions without requiring external connectivity, thereby supporting precision medicine in ambulatory settings. In addition, smart rings are gaining traction due to improved measurement accuracy from finger-based sensors and enhanced comfort for 24-hour wear.

Furthermore, increasing partnerships and collaborations withing the industry contribute to market growth. For instance, partnerships between French firms and global startups, such as Livingston's collaboration for biosensors and wearables in June 2025, enable scalable production and global market reach. This expansion supports personalized fitness, wellness, and lifestyle applications, reflecting increasing adoption among fitness enthusiasts and urban consumers.

"The diagnostics industry has changed post COVID, wearable technology has risen up the agenda, along with AI having an increasing impact, and we think the collaboration with Linxens will keep us ahead of the curve while significantly improving our market reach."

Kevin Fallon, FlexMedical's CEO and co-founder,

"This collaboration expands our biosensor portfolio by integrating functionalisation capabilities, enabling us to deliver end-to-end solutions - from flex-PCB or printed electrodes to fully functional sensor platforms. Together, we streamline the journey from R&D to mass production, accelerating the delivery of innovative diagnostic solutions."

Minh Le, vice-president of Linxens Healthcare

Global Biosensors Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biosensors market report based on technology, application, end use, and region.

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Thermal
  • Electrochemical
  • Piezoelectric
  • Optical
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Medical
    • Cholesterol
    • Blood Glucose
    • Blood gas analyzer
    • Pregnancy testing
    • Drug discovery
    • Infectious disease
  • Food Toxicity
  • Bioreactor
  • Agriculture
  • Environment
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Home Healthcare Diagnostics
  • PoC Testing
  • Food Industry
  • Research Laboratories
  • Security and Bio-defense
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Technology Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Biosensors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Biosensors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. Biosensors Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Biosensors Market Application Movement Analysis
  • 4.3. Global Biosensors Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Medical
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.2. Cholesterol
      • 4.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.3. Blood Glucose
      • 4.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.4. Blood Gas Analyzer
      • 4.4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.5. Pregnancy Testing
      • 4.4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.6. Drug Discovery
      • 4.4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.7. Infectious Disease
      • 4.4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Food Toxicity
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Bioreactor
    • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Agriculture
    • 4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8. Environment
    • 4.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Biosensors Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Biosensors Market Technology Movement Analysis
  • 5.3. Global Biosensors Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Thermal
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Electrochemical
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Piezoelectric
    • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Optical
    • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Biosensors Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Biosensors Market End Use Movement Analysis
  • 6.3. Global Biosensors Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Home Healthcare Diagnostics
    • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. PoC Testing
    • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Food Industry
    • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Research Laboratories
    • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8. Security and Bio-defense
    • 6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Biosensors Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Abbott Laboratories
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Medtronic
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Biosensors International Group
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Pinnacle Technology, Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Dupont.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Sensirion AG
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Thermo Fisher Scientific, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. F. Hoffmann-La Roche AG
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Siemens Healthineers
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Zimmer & Peacock AS
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Metrohm AG
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. DexCom, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Universal Biosensors, Inc.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. Johnson & Johnson Services, Inc.
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. Nix Biosensors
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Product benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Cyrcadia Health
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Product benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Lifescan
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Product benchmarking
      • 8.4.17.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global biosensors market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 4 Global biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 5 Global biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 8 North America biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 9 North America biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 11 U.S. biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 12 U.S. biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 14 Canada biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 15 Canada biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 17 Mexico biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 18 Mexico biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 21 Europe biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 22 Europe biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 24 UK biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 25 UK biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Germany biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 27 Germany biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Germany biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 30 France biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 31 France biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 33 Italy biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 34 Italy biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 36 Spain biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 37 Spain biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 39 Denmark biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 40 Denmark biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 42 Sweden biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 43 Sweden biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 45 Norway biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 46 Norway biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 52 China biosensors market, by modality, 2021 - 2033 (USD Million)
  • Table 53 China biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 54 China biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 55 Japan biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 56 Japan biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 57 Japan biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 58 India biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 59 India biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 60 India biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 61 South Korea biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 62 South Korea biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 63 South Korea biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 64 Australia biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 65 Australia biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 66 Australia biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 67 Thailand biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 68 Thailand biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 69 Thailand biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Latin America biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 71 Latin America biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 72 Latin America biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 73 Latin America biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 74 Brazil biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 75 Brazil biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 76 Brazil biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 77 Argentina biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 78 Argentina biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 79 Argentina biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 80 MEA biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 81 MEA biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 82 MEA biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 83 MEA biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 84 South Africa biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 85 South Africa biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 86 South Africa biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 90 UAE biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 91 UAE biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 92 UAE biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 95 Kuwait biosensors market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Market formulation & validation
  • Fig. 5 Biosensors market: Market outlook
  • Fig. 6 Biosensors market: Segment outlook
  • Fig. 7 Biosensors market: Competitive landscape outlook
  • Fig. 8 Parent market outlook
  • Fig. 9 Biosensors market driver impact
  • Fig. 10 Biosensors market restraint impact
  • Fig. 11 Biosensors market: Technology outlook and key takeaways
  • Fig. 12 Biosensors market: Technology movement analysis
  • Fig. 13 Thermal market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Electrochemical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Piezoelectric market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Optical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Biosensors market: Application outlook and key takeaways
  • Fig. 18 Biosensors market: Application movement analysis
  • Fig. 19 Medical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Cholesterol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Blood glucose market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Blood gas analyzer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Pregnancy testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Infectious disease market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Food toxicity market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Bioreactor market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Agriculture market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Environment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Biosensors market: End use outlook and key takeaways
  • Fig. 32 Biosensors market: End use movement analysis
  • Fig. 33 Home healthcare diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 PoC testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Food industry market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Research laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Security and bio-defense market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Global biosensors market: Regional outlook and key takeaways
  • Fig. 39 Global biosensors market: Regional movement analysis
  • Fig. 40 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. key country dynamics
  • Fig. 42 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Canada key country dynamics
  • Fig. 44 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Mexico key country dynamics
  • Fig. 46 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 UK key country dynamics
  • Fig. 49 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Germany key country dynamics
  • Fig. 51 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 France key country dynamics
  • Fig. 53 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Italy key country dynamics
  • Fig. 55 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Spain key country dynamics
  • Fig. 57 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Denmark key country dynamics
  • Fig. 59 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Sweden key country dynamics
  • Fig. 61 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Norway key country dynamics
  • Fig. 63 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Japan key country dynamics
  • Fig. 66 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 China key country dynamics
  • Fig. 68 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 India key country dynamics
  • Fig. 70 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Thailand key country dynamics
  • Fig. 72 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 South Korea key country dynamics
  • Fig. 74 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Australia key country dynamics
  • Fig. 76 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Brazil key country dynamics
  • Fig. 79 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Argentina key country dynamics
  • Fig. 81 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 South Africa key country dynamics
  • Fig. 84 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Saudi Arabia key country dynamics
  • Fig. 86 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 UAE key country dynamics
  • Fig. 88 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Kuwait key country dynamics
  • Fig. 90 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)